Orchard Therapeutics Plc ADR (ORTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Sales | 22,655 | 1,675 | 2,595 | 2,513 | 2,076 |
| Cost of Goods | 6,771 | 226 | 857 | 805 | 422 |
| Gross Profit | 15,884 | 1,449 | 1,738 | 1,708 | 1,654 |
| Operating Expenses | 143,743 | 142,108 | 159,573 | 175,386 | 237,107 |
| Operating Income | -127,088 | -140,433 | -156,978 | -172,873 | -235,031 |
| Interest Expense | 3,079 | 2,497 | 2,328 | 1,538 | 0 |
| Other Income | -22,867 | -826 | 6,596 | 8,749 | 5,506 |
| Pre-tax Income | -153,034 | -143,756 | -152,710 | -165,662 | -229,525 |
| Income Tax | -2,374 | 828 | -731 | -2,240 | 970 |
| Net Income Continuous | -150,660 | -144,584 | -151,979 | -163,422 | -230,495 |
| Net Income | $-150,660 | $-144,584 | $-151,979 | $-163,422 | $-230,495 |
| EPS Basic Total Ops | -1.18 | -1.17 | -15.30 | -17.50 | -102.20 |
| EPS Basic Continuous Ops | -1.18 | -1.17 | -15.28 | -17.53 | -102.17 |
| EPS Diluted Total Ops | -1.18 | -1.17 | -15.30 | -17.50 | -102.20 |
| EPS Diluted Continuous Ops | -1.18 | -1.17 | -15.28 | -17.53 | -102.17 |
| EPS Diluted Before Non-Recurring Items | -11.80 | -11.70 | -15.30 | -17.50 | -102.20 |
| EBITDA(a) | $-124,926 | $-137,629 | $-156,617 | $-175,729 | $-240,132 |